Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
Dec 5, 2025, 9:30 AM EST
-33.33%
Market Cap 1.25M
Revenue (ttm) n/a
Net Income (ttm) -342.81K
Shares Out 13.86M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,000
Average Volume 24,965
Open 0.0900
Previous Close 0.0900
Day's Range 0.0900 - 0.0900
52-Week Range 0.0700 - 0.4500
Beta 1.44
RSI 50.15
Earnings Date Mar 5, 2026

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.